On ECHEMI
Home > Drugs > Lamotrigine Registered Holders
Lamotrigine structure

Lamotrigine structure

Lamotrigine

Lamotrigine(BW430C) is a novel anticonvulsant drug for inhibition of 5-HT and sodium channelTarget: Sodium ChannelLamotrigine stabilises presynaptic neuronal membranes by blockade of voltage-dependent sodium channels, thus preventing the release of excitatory neurotransmitters, particularly glutamate and aspartate [1]. In rat cerebral cortex tissue incubated with veratrine 10 mg/L, lamotrigine is twice as potent in inhibiting the release of glutamate and aspartate (ED 50 = 5.38 mg/L for

Find 61 Related Holders

CTX LIFE SCIENCES PVT LTD
United States United States

API Registration Country

API Active
SUVEN PHARMACEUTICALS LTD
United States United States

API Registration Country

API Active
UNIMARK REMEDIES LTD
United States United States

API Registration Country

API Active
MATRIX PHARMACORP PRIVATE LTD
United States United States

API Registration Country

API Active
ALEMBIC PHARMACEUTICALS LTD
United States United States

API Registration Country

API Active
APITORIA PHARMA PRIVATE LTD
United States United States

API Registration Country

API Active
SMS Pharmaceuticals Ltd
United States United States

API Registration Country

API Active
JUBILANT PHARMOVA LTD
United States United States

API Registration Country

API Active
ZYDUS LIFESCIENCES LTD
United States United States

API Registration Country

API Active
SYN-TECH CHEM AND PHARM CO LTD
United States United States

API Registration Country

API Active
Recommended Suppliers of Lamotrigine
View 138 Suppliers Request for Quotation
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.